0
La Jolla Pharmaceutical Company Banner Image

La Jolla Pharmaceutical Company

  • Ticker LJPC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
La Jolla Pharmaceutical Company Logo Image
  • 51-200 Employees
  • Based in San Diego, California
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company engages in developing LJPC-501, an angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome; and GCS-100, a galectin-3 inhibitor for the potential treatmentMore of chronic kidney disease.
La Jolla Pharmaceutical Company

Most Recent Annual Report

La Jolla Pharmaceutical Company MOST RECENT 2019 Annual Report and Form 10K

Report Locked. La Jolla Pharmaceutical Company has reached its limit for free report views.

Older/Archived Annual Reports